A Phase 2, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Miconazole Nitrate 2% + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis
Latest Information Update: 06 Mar 2024
At a glance
- Drugs Domiphen bromide/miconazole (Primary)
- Indications Vulvovaginal candidiasis; Vulvovaginitis
- Focus Therapeutic Use
- 30 Jan 2024 Top-line Results from this trial presented in a Hyloris Pharmaceuticals media release.
- 06 Sep 2023 According to a Hyloris Pharmaceuticals media release, a full read-out of the study expected shortly.
- 15 Mar 2023 According to a Hyloris Pharmaceuticals media release, recruitment for this study is completed and last patient last visit (LPLV) will have occurred by Q2 2023. The results of this study will guide the Company for the preparation and design of the next clinical trial.